Patients Cannot Be Forced To Buy Medicines From Hospital-Attached Shops: Maharashtra FDA

Pune : Patients cannot be compelled to purchase medicines from hospital-attached drug stores, the Maharashtra Food & Drug Administration (FDA) has said.

A notification issued by Commissioner, FDA, Abhimanyu Kale said FDA had received repeated complaints that patients have been forced to buy medicines from the drug store in hospitals.

“It is illegal for a hospital to force patients to buy medicines from their affiliated stores,” said the notification, addressed to all the divisional joint commissioners, assistant commissioners, and drug inspectors (Drugs).

Patients don’t need to purchase medicines from hospital-affiliated shops and the same can be purchased from any licensed drug store, it said.

The hospitals concerned should prominently display a signboard at a prominent place visible to the patients, as per the notification.

  • Related Posts

    • Pharma
    • June 25, 2025
    • 79 views
    Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

    A major face-off is expected in India’s growing anti-obesity treatment market, as Danish pharma giant Novo Nordisk rolled out its blockbuster weight-loss drug Wegovy on Tuesday, just a month after…

    • Pharma
    • June 25, 2025
    • 105 views
    Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

    Hyderabad:  Aurobindo Pharma Ltd wholly owned step-down subsidiary CuraTeQ Biologics has obtained marketing authorization from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) for Dyrupeg, its pegylated filgrastim biosimilar…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

    Novo Nordisk launches blockbuster weight-loss drug Wegovy in India; Check price, dosage and other details

    Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

    Aurobindo Pharma arm gets marketing authorization in UK for Dyrupeg

    Sun Pharma’s European partner withdraws application for skin cancer treatment therapy

    Sun Pharma’s European partner withdraws application for skin cancer treatment therapy

    Glenmark Pharma launches TEVIMBRA in India

    Glenmark Pharma launches TEVIMBRA in India